Myriad Genetics (MYGN) Non Operating Income (2009 - 2026)
Myriad Genetics (MYGN) reported Non Operating Income of -$3.4 million for Q1 2026, down 3500.0% year-over-year from $100000.0 in Q1 2025, and up 59.04% quarter-over-quarter from -$8.3 million in Q4 2025.
Myriad Genetics (MYGN) Non Operating Income (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of Non Operating Income data on file, last reported at -$3.4 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$3.4 million, down 3500.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.7 million (down 746.67% YoY), and the FY2025 annual result was -$7.9 million, down 818.18% from the prior year.
- Non Operating Income climbed to -$3.4 million in Q1 2026 per MYGN's latest filing, from -$8.3 million in the prior quarter.
- Over five years, Non Operating Income peaked at $2.0 million in Q1 2024 and troughed at -$8.3 million in Q4 2025.
- A 5-year average of -$1.0 million and a median of -$650000.0 in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2026: Non Operating Income jumped 600.0% in 2024, then slumped 3500.0% in 2026.
- A 5-year view of Non Operating Income shows it stood at -$600000.0 in 2022, then sank by 50.0% to -$900000.0 in 2023, then surged by 133.33% to $300000.0 in 2024, then plunged by 2866.67% to -$8.3 million in 2025, then soared by 59.04% to -$3.4 million in 2026.
- Business Quant data shows MYGN's Non Operating Income at -$3.4 million in Q1 2026, -$8.3 million in Q4 2025, and $400000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -4.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 9.60 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 7.33 Mn |
| 10 | Myriad Genetics | 411.34 Mn | 286.94 Mn | 137.60 Mn | -3.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.40 Mn |
| Dec 31, 2025 | -8.30 Mn |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | -1.40 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | -1.20 Mn |
| Jun 30, 2024 | -700,000.00 |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -900,000.00 |
| Sep 30, 2023 | -1.10 Mn |
| Jun 30, 2023 | -2.40 Mn |
| Mar 31, 2023 | -400,000.00 |
| Dec 31, 2022 | -600,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Dec 31, 2021 | 5.50 Mn |
| Sep 30, 2021 | 120.60 Mn |
| Jun 30, 2021 | 18.80 Mn |
| Mar 31, 2021 | -2.90 Mn |